Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelaic Acid and Tranexamic Acid in Melasma
NCT07727954Completed
- Sponsor
- Universidad de Guadalajara
- Start
- Jun 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of azelaic acid 15% gel vehicle and tranexamic acid in melasma (2 arms), sponsored by Universidad de Guadalajara. Primary endpoint: Melasma Area and Severity Index at 4 weeks. Started Jun 2026; status: completed.
02
Drugs
azelaic acid 15% gel vehicletranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07727954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07727954.